Group One Trading’s Rubius Therapeutics, Inc RUBY Stock Holding History

Group One Trading’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,920	Closed	-$1.71K	–	8278
2022 Q4	$1.71K	Sell	9,920 -1	-0%	–	﹤0.01%	6702
2022 Q3	$4K	Sell	9,921 -24,946	-72%	-$18.7K	﹤0.01%	6986
2022 Q2	$30K	Buy	34,867 +4,032	+13%	+$6.77K	﹤0.01%	5989
2022 Q1	$170K	Buy	30,835 +29,676	+2,560%	+$188K	﹤0.01%	4976
2021 Q4	$11K	Buy	+1,159	New	+$16.1K	﹤0.01%	7328

Other funds holding RUBY

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Group One Trading's RUBY Position: Q1 2023 in Review

Group One Trading sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 9,920 shares — an estimated $1.71K sold.

Group One Trading first reported a position in RUBY in Q4 2021 and held it in 5 quarters. The position peaked at $170K in Q1 2022. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

Group One Trading reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
Group One Trading sold 9,920 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $1.71K.
Group One Trading first reported a position in Rubius Therapeutics, Inc in Q4 2021 and held it in 5 quarters.
Group One Trading's Rubius Therapeutics, Inc position peaked at $170K in Q1 2022.
7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.